Redox-OPC -Fruit extract Antioxidant (Capsule)
Natural health product licensed in Canada
- Other names
- Dr Nutrition Redox-OPC -Fruit extract Antioxidant (Capsule), MapleLife Nutrition Redox-OPC -Fruit extract Antioxidant (Capsule)
- Licence holder
- Nutralab Canada Corp.
- NPN or DIN-HM
- 80075354
- Status
- Active licence
- Licence date
- 31 January 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 20 milligramme Potency : 70 % Catechins | 5 milligramme | Not calculated |
| Camellia sinensis Source : Feuille Potency : 95 % Polyphenols | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 0.5 % Caffeine | Not specified | Not calculated |
| trans-3,5,4'-Trihydroxystilbéne Source : Resvératrol | 100 milligramme | Not calculated |
| Punica granatum Source : Fruit | 30 milligramme | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 100 milligramme Potency : 85 % Oligomeric proanthocyanidins | 10 milligramme | Not calculated |
| Lycium barbarum Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 5,000 milligramme | 500 milligramme | Not calculated |
| Euterpe oleracea Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 40 milligramme | 10 milligramme | Not calculated |
| Vaccinium corymbosum Source : Fruit Extract : Matériel brut sec Extraction ratio : 18:1 Dry plant equivalent : 180 milligramme | 10 milligramme | Not calculated |
| Vaccinium macrocarpon Source : Fruit | 50 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of antioxidants for the maintenance of good health. Helps to relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs. Goji is traditionally used to nourish liver and kidney and replenish essence to improve vision.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, do not use this product. Relief of symptoms related to non-complicated CVI: Consult a health care practitioner if symptoms worsen. If you are taking any prescription medication, consult a health care practitioner prior to use. If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner.
Source
Official Health Canada record, licence 80075354
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.